Joost Daemen

Interventional cardiologist

Thoraxcenter, Erasmus University Medical Center, Rotterdam, the Netherlands

  • LinkedIn
  • Radcliffe

Biography

Dr Joost Daemen, MD, PhD obtained his degree in medicine at the Erasmus University Medical Center, Rotterdam in 2005 and did 2 years of internal medicine training and 4 years of general cardiology training at the Thoraxcenter, Rotterdam. 

Dr Daemen is actively involved in several drug-eluting stent trials and is Principal Investigator of 4 trials focusing on the safety and efficacy of renal sympathetic denervation in hypertension, heart failure, vasospastic angina and heart failure. Dr Daemen is a member of the editorial board of EuroIntervention and the Netherlands Heart Journal, member of Young ICIN, and has completed courses in biomedical statistics and device training.

Articles

The Coronary Intravascular Lithotripsy System

Joost Daemen, Maria Natalia Tovar Forero,

Published:

Citation: Interventional Cardiology Review 2019;14(3):174–81.

Cardiovascular Clinical Trials in a Pandemic: Immediate Implications of Coronavirus Disease 2019

Ernest Spitzer, Ben Ren, Jasper J Brugts,

Published:

Citation: Cardiac Failure Review 2020;6:e09.

A42 - Pressure and Volume Unloading with Pulsatile Circulatory Support During High-risk Percutaneous Revascularisation

MB Bastos, JJ Schreuder, Joost Daemen,

Published:

Citation: Interventional Cardiology Review 2019;14(3 Suppl 1):A42.

The CONTRACT Study: Navvus Fractional Flow Reserve to Reduce Contrast, Cost and Radiation

Joost Daemen,

Published:

Citation: Interventional Cardiology Review, 2016;11(Suppl):3-4.